Literature DB >> 22214274

Seroepidemiology of Toxoplasma gondii infection in Tepehuanos in Durango, Mexico.

Cosme Alvarado-Esquivel1, Sergio Estrada-Martínez, Claudia Rosalba García-López, Amparo Rojas-Rivera, Antonio Sifuentes-Álvarez, Oliver Liesenfeld.   

Abstract

The epidemiology of Toxoplasma gondii infection is known to depend on a number of behavioral factors, including contact with animals and eating habits. The epidemiology in specific populations (i.e., in indigenous ethnic groups) is not well studied. We therefore investigated the presence of anti-Toxoplasma IgG and IgM antibodies in 156 Tepehuanos, an indigenous ethnic group in Durango State in northern Mexico, using ELISAs. Of the 156 Tepehuanos (mean age 31.03±16.71 years), 35 (22.4%) had anti-Toxoplasma IgG antibodies. IgG levels of 14-99, 100-150, and >150 IU/mL were found in 15 (42.9%), 1 (2.8%), and 19 (54.3%) anti-Toxoplasma IgG-positive Tepehuanos, respectively. Also, 15 (9.6%) subjects had anti-Toxoplasma IgM antibodies. Male Tepehuanos aged 31-50 years showed a significantly higher frequency of exposure to T. gondii than female Tepehuanos of the same age. Seroprevalence of anti-T. gondii IgM antibodies was significantly higher in Tepehuanos without education than those with 7-12 years of education. Tepehuanos suffering from frequent headaches had significantly higher seroprevalences of anti-T. gondii IgG and IgM antibodies than those without this clinical feature. In addition, Tepehuanos suffering from hearing impairment had significantly higher seroprevalence of anti-T. gondii IgM antibodies than those without this clinical feature. Logistic regression analysis did not show an association of T. gondii exposure with any behavioral characteristics, including contact with cats or eating habits. The seroprevalence of T. gondii exposure in Tepehuanos is comparable to that reported in other populations in North America; however, seroprevalence in the largely rural Tepehuanos is higher than that reported in a nearby urban center. Toxoplasma may be impacting the health of Tepehuanos. This is the first report of T. gondii infection in Tepehuanos, and the results should prove useful for the design of preventive measures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214274     DOI: 10.1089/vbz.2011.0747

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  12 in total

Review 1.  A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population.

Authors:  Ma de la Luz Galvan-Ramirez; Rogelio Troyo; Sonia Roman; Carlos Calvillo-Sanchez; Rosamaria Bernal-Redondo
Journal:  Parasit Vectors       Date:  2012-11-26       Impact factor: 3.876

2.  High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status.

Authors:  Cosme Alvarado-Esquivel; Alejandro Torres-Castorena; Oliver Liesenfeld; Sergio Estrada-Martínez; Jesús D Urbina-Álvarez
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

Review 3.  Toxoplasmosis in Mexico: epidemiological situation in humans and animals.

Authors:  Ivonne Hernández-Cortazar; Karla Y Acosta-Viana; Antonio Ortega-Pacheco; Eugenia del S Guzman-Marin; Armando J Aguilar-Caballero; Matilde Jiménez-Coello
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

4.  Toxoplasma gondii infection in interstate truck drivers: a case-control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesús Hernández-Tinoco; Misael Salcedo-Jáquez; Luis Francisco Sánchez-Anguiano; Luis Omar Berumen-Segovia; Elizabeth Rábago-Sánchez; Oliver Liesenfeld
Journal:  Parasit Vectors       Date:  2015-02-05       Impact factor: 3.876

5.  Serosurvey of Entamoeba Histolytica Exposure among Tepehuanos Population in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Agar Ramos-Nevárez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola
Journal:  Int J Biomed Sci       Date:  2015-06

6.  Seroprevalence of Toxoplasma gondii infection and associated risk factors in Huicholes in Mexico.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Luis Omar Berumen-Segovia; Francisco Javier Imard Rodríguez-Acevedo; Isabel Beristain-García; Elizabeth Rábago-Sánchez; Oliver Liesenfeld; Federico Campillo-Ruiz; Oscar Alberto Güereca-García
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

7.  High Prevalence of Toxoplasma gondii Infection in Miners: A Case-Control Study in Rural Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesus Hernandez-Tinoco; Luis Omar Berumen-Segovia; Luis Francisco Sanchez-Anguiano; Sergio Estrada-Martinez; Ada Agustina Sandoval-Carrillo; Jose Manuel Salas-Pacheco; Oliver Liesenfeld; Elizabeth Irasema Antuna-Salcido
Journal:  J Clin Med Res       Date:  2016-10-26

8.  Seroepidemiology of infection with Toxoplasma gondii in migrant agricultural workers living in poverty in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Federico Campillo-Ruiz; Oliver Liesenfeld
Journal:  Parasit Vectors       Date:  2013-04-20       Impact factor: 3.876

9.  Seroepidemiology of Helicobacter pylori Infection in Tepehuanos Aged 15 Years and Older in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel
Journal:  J Pathog       Date:  2013-03-20

10.  Seroepidemiology of Toxoplasma Gondii Infection in People Applying for Medical Certificates.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco; Rosa Angélica Pulido-Montoya; Guadalupe Acosta-Rojas; Sergio Estrada-Martínez; Alma Rosa Pérez-Álamos; Raquel Vaquera-Enriquez; Arturo Díaz-Herrera; Raúl Segura-Moreno; María de Lourdes Guerrero-Carbajal; Oliver Liesenfeld; Isabel Beristain García; María Guadalupe Rentería-López
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.